RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Testing light therapy for movement and thinking symptoms

Researchers investigate light therapy directed towards the front of the brain for movement and thinking symptoms in Parkinson’s.

Testing a treatment or activity · Study reference: NCT06916260

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (planned)
2025-04-04
Main measurements finished (planned)
2026-01-29
Study finished (planned)
2026-07-30

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 50 years to 80 years · Does not accept healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion Criteria: * Diagnosis of Parkinson disease Exclusion Criteria: 1. Participants who are unable to comply with study visit/testing requirements (e.g. participants who cannot go off PD medication for the pre-, post-, and 3-month assessments). 2. Participants who are unable to provide consent. 3. Participants with a Deep Brain Stimulation (DBS) device. 4. Participants who have a history of a psychiatric disorder 5. Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc. 6. Participants with a clinical diagnosis of PD that is not considered primary (e.g. vascular parkinsonism) or participants where an atypical form of parkinsonism is suspected (e.g., progressive supranuclear palsy, multiple system atrophy). 7. Participants with a history of cancer (whether treated with chemotherapy and/or radiotherapy or not). 8. Participants with a history of a recent concussion or any facial, neck, or head injury within the last 6 months. UD IRB Approved: 03/12/2025 IRBNet ID#: 2277769-2 I/C from Rev. 01/2024 Page 3 of 10 Participant's Initial's \_\_\_\_\_\_\_\_ 9. Known injury or disease that might interfere with motor function in the proposed experiments (e.g., stroke, traumatic brain injury, extrapyramidal dysfunction, neuromuscular disease, orthopedic problems that impair movement). 10. Participants with a history of photosensitivity. 11. Participants who are not able to walk unassisted for 2 minutes
Full study name & original research details

Official study title

Light Therapy Intervention in Individuals With Parkinson's Disease

Original description

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.

Conditions reported: Parkinson Disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Interventional
Interventions
Red Light (PDT); Placebo
Phases
NA
Sponsor
University of Delaware
Start date reported by registry
2025-04-04 (estimated)

Registry updated: 2025-04-08 · Status last verified by the registry submitter: 2025-02

Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Sara Penuela, PhD student · 9739740120 · penuelas@udel.edu

Roxana Burciu, PhD, Associative Professor · rgburciu@udel.edu

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

University of Delaware STAR Tower

Newark, Delaware, United States

Recruiting

Sara Penuela, PhD Student · 973-974-0120 · penuelas@udel.edu

John Jeka, PdD · jjeka@udel.edu

sara Penuela, PhD student

John Jeka, PhD

Roxana Burciu, PhD

Thomas Buckley, PhED

Facility not reported

United States

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.